Radiation Pneumonitis After SBRT for NSCLC

• Register: ClinicalTrials.gov
• Last refreshed on: 30 January 2023
• Main ID: NCT02428049
• Date of registration: 15/04/2015
• Prospective Registration: No
• Primary sponsor: Sykehuset i Vestfold HF
• Public title: Radiation Pneumonitis After SBRT for NSCLC
• Scientific title: Lung Function After Curatively Intended Radiotherapy for Non-small-cell Lung Carcinoma, -Changes and Predictive Markers
• Date of first enrolment: October 2013
• Target sample size: 105
• Recruitment status: Active, not recruiting
• URL: https://clinicaltrials.gov/show/NCT02428049
• Study type: Observational

Countries of recruitment

Norway

Key inclusion & exclusion criteria

Inclusion Criteria:

- Age > 18 years old

- Current lung cancer, not older than 8 weeks

- Received written consent

- Non small cell lung cancer

- Stage IA-IIIA

- Inoperable

Exclusion Criteria:

- Lack of consent

- Operable

- Additional cancer disease

- Small cell lung carcinoma or neuroendocrine lung cancer



Age minimum: 18 Years
Age maximum: N/A
Gender: All

Health Condition(s) or Problem(s) studied

Lung Cancer

Lung Function Changes

Radiotherapy

Intervention(s)

Radiation: Stereotactic or conventional radiotherapy and chemotherapy in curative intent

Primary Outcome(s)

permanently reduced lung function [Time Frame: 2 years]

Secondary Outcome(s)

predictive value of pulmonary function tests for the development of a permanent reduction in lung function after curative radiotherapy [Time Frame: 2 years]

Secondary ID(s)

2013/169

Source(s) of Monetary Support

Please refer to primary and secondary sponsors

Secondary Sponsor(s)

Oslo University Hospital

Norwegian Radium Hospital